TELL US WHERE YOUR PATHWAY IS UNDER PRESSURE
If you are considering additional Clinical Insourcing capacity, tell us briefly about the treatment area, patient cohort or pathway challenge.
Your enquiry will be reviewed by the appropriate ProMedical clinical, operational and commercial leads, and we will contact you directly to arrange a brief initial discussion.
Appointed to multiple national Clinical Insourcing frameworks
Consultant-led services | Dedicated multidisciplinary teams | Structured mobilisation and robust clinical governance alignment
WHAT HAPPENS NEXT?
We review your pathway requirement
Your enquiry is considered by the appropriate ProMedical clinical, operational and commercial leads so that the first conversation is relevant to your requirement.
We speak with you directly
We arrange a brief discussion to understand the patient cohort, where the pathway is constrained, the operational dependencies and the outcome you need to achieve.
Where appropriate, we move into operational scoping
If there is a potential fit, we work with your clinical and operational teams to understand the requirement in greater detail before developing a proposed delivery model.
The initial discussion is exploratory only. It does not commit your organisation to progress with ProMedical, adopt a particular delivery model or procurement route, or incur any cost.
WHY PROMEDICAL?
Clinical leadership and quality assurance
Consultant-led Clinical Insourcing delivered through dedicated multidisciplinary teams, with the clinical scope, patient selection parameters, responsibilities and quality requirements agreed with your teams.
Built Around your Local Service
Delivery is aligned to your local pathways, policies, clinical protocols, systems, escalation arrangements and operational requirements - rather than asking your teams to adapt around a pre-set model.
Structured mobilisation
Mobilisation can include pathway mapping, patient selection, systems access, MDT onboarding, alignment to agreed governance arrangements and operational safety checks, with readiness confirmed before clinical activity begins.
Clear clinical oversight and reporting
Agreed reporting provides visibility of activity, utilisation, quality, risks, patient outcomes and outstanding clinical actions throughout delivery, supported by regular service review with your teams.
Our services are designed to operate as a safe extension of your existing clinical service.
CLINICAL QUALITY WITH COMMERCIAL DISCIPLINE
With NHS budgets under sustained pressure, additional capacity must be clinically robust, operationally deliverable and commercially credible.
Across comparable Clinical Insourcing programmes, ProMedical’s pricing has averaged approximately
25% below the applicable NHS Payment Scheme unit price.
In some theatre-based pathways, the differential has been greater.
Actual pricing varies according to treatment area, case mix, pathway scope, site requirements, infrastructure and agreed responsibilities. Comparisons apply where a comparable NHS Payment Scheme unit price is available.
Have a pathway requirement you would like to discuss?
You can speak with us at an early stage. We do not need a completed service specification or fully developed delivery model to begin understanding the pressure within your pathway.
Looking for more information first?
Explore ProMedical’s wider Clinical Insourcing service, delivery approach, clinical governance and treatment-area capabilities.